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Organophosphate pesticide (OP) poisoning is quite common and can cause cardiovascular complications and even direct 
myocardial injury. However, no guideline has included an acute poisoning as a potential cause for a type 2 myocardial 
infarction (MI) so far. Here we present a case of a 61-year-old woman brought by ambulance to emergency department 
one hour after accidental ingestion of an unknown quantity of a solution she used against flea infestation. The patient 
presented with dizziness, myosis, excessive sweating, hypersalivation, sphincteric incontinence, muscle fasciculation, 
tremor of the extremities, pale skin, alcoholic and pesticide breath odour. Even though we had no guidelines to fall back 
on, we successfully treated the patient with low-molecular-weight heparin, antiplatelets, statin, diltiazem, antidote therapy, 
and supportive care. Physicians should be aware that OP poisoning can induce type 2 MI as a complication within a few 
hours since exposure, and emergency management should always include close cardiac monitoring.
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Type 2 myocardial infarction (MI) occurs as a 
consequence of imbalance between myocardial oxygen 
demand and supply and involves different mechanisms such 
as endothelial dysfunction of the coronary arteries, 
vasculitis, dysrhythmias, vasospasm, coronary embolism, 
severe bradyarrhythmia, respiratory failure with severe 
hypoxaemia, severe anaemia, and hypotension/shock (1). 
Although there is no specific mention of type 2 MI in the 
wake of acute poisoning, MI has been reported after acute 
carbon monoxide (2) and organophosphate (OP) pesticide 
poisoning (3–6), but these cases are exceptionally rare.
It is known, however, that severe OP poisoning can 
cause direct myocardial injury (7) and several cardiovascular 
complications, including electrocardiogram (ECG) 
abnormalities, MI, impaired systolic and diastolic 
performance, functional remodelling, and histopathological 
findings (8). To the best of our knowledge, here we present 
the first case of type 2 MI as a result of accidental acute OP 
poisoning in a 61-year-old woman without cardiovascular 
risk factors who was chronically occupationally exposed 
to OP pesticides.
CASE PRESENTATION
A 61-year-old woman was brought to the emergency 
department (ED) by ambulance one hour after accidental 
ingestion of an unknown quantity of OP solution from a 
bottle she confused for a drink. She came from a rural area 
where she had worked in agriculture and had been 
occupationally exposed to OP, carbamate, and organochlorine 
pesticides through inhalation and skin contact for 10 years. 
She had a history of surgery for post-traumatic subdural 
haematoma three years before the accident, without other 
known cardiovascular risk factors. She presented with 
clinical signs and symptoms of dizziness, myosis, excessive 
sweating, hypersalivation, sphincteric incontinence, muscle 
fasciculation, tremor of the extremities, pale skin, and 
alcoholic and pesticide breath odour. Her Glasgow Coma 
Scale was 9, and she was uncooperative, which made taking 
clinical history very difficult. Her initial blood pressure was 
200/100 mmHg, and the first ECG in the ED showed narrow 
QRS-complex tachycardia with a heart rate of 122/min. 
Arterial blood gas analysis revealed lactic acidosis (pH 
7.26), lactate 6.3 mmol/L, bicarbonate 18.8 mmol/L, 
potassium 2.5 mmol/L, calcium 1.05 mmol/L. Laboratory 
findings detected leukocytosis (16.93x103/µL), neutrophilia 
(13.9x103/µL), hyperglycaemia (12.71 mmol/L), and an 
ethanol level of 215 mg/dL. Relative reference ranges of 
our laboratory are: white blood cells 4–10x103/µL, 
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neutrophils 2–8x103/µL, glucose 4.55–5.55 mmol/L, and 
ethanol <10 mg/dL. Cardiac markers were also elevated 
upon ED admission: creatine kinase (CK) was 412 U/L 
(reference range 20–170 U/L), CK myocardial band (CK-
MB) 73 U/L (ref. range 2–25 U/L), lactate dehydrogenase 
(LDH) 292 U/L (ref. range 135–214 U/L), N-terminal pro-
brain natriuretic peptide (NT-proBNP) 524 pg/mL, cardiac 
troponin I (cTnI) 1.75 ng/mL (ref. range 0–0.02 ng/mL), 
and GOT 32 U/L (ref. range 5–32 U/L). The plasma 
cholinesterase level was 279 U/L (range 5320–12920 U/L). 
Other biological parameters were within normal ranges.
These findings pointed to acute OP pesticide poisoning 
(based on muscarinic and nicotinic signs and symptoms), 
and treatment was immediately started in the ED with 
oxygen therapy face mask (4 L/min), intravenous (iv) 
antidote (combining 2 mg atropine and the initial bolus of 
250 mg obidoxime), and gastric lavage. The patient was 
then transferred to a medical ward, where she regained full 
consciousness and became cooperative. Physical 
examination one hour after ED admission established 
150/100 mmHg blood pressure, 122/min heart rate, and 
mydriatic pupils. She had a body mass index of 24.4 kg/
m2, she denied smoking, and declared occasional alcohol 
drinking. ECG showed ST segment depression in leads 
V3-V4, T flat in D1, aVL, V5-V6, but no signs of 
hypokalaemia (Figure 1A). Antidote therapy continued with 
1 mg atropine every hour (with reassessment of heart rate 
and pupil diameter every 15 min) and slow continuous iv 
obidoxime administration (1 g/24 h), combined with 
diazepam (5 mg), which led to resolution of the muscarinic 
signs and muscle fasciculations within three hours of first 
antidote administration. ECG in the medical ward showed 
48 % ejection fraction of the left ventricle (LVEF), 24 % 
fractional shortening (FS), calcification of the aortic knob, 
no valve lesion, and no segmental wall motion abnormalities 
or thrombi. Clinical observation continued hourly and 
showed mydriatic pupils. Paraclinical parameters were also 
monitored, and hydro-electrolyte correction was continued. 
Careful atropine administration also continued to control 
muscarinic signs and symptoms because of the initial sinus 
tachycardia.
Six hours after the initial assessment at the ED, cardiac 
enzymes and biomarkers were as follows: cTnI 2.89 ng/mL, 
NT-proBNP 1314 pg/mL, CK 1389 U/L, CK-MB 104 U/L, 
TGO 89U/L, and LDH 354 U/L. At 28 h, their values peaked 
to cTnI 6.84 ng/mL, NT-proBNP 14,774 pg/mL, CK 
2614 U/L, CK-MB 125 U/L, TGO 148 U/L, and LDH 
484 U/L. ECG monitoring showed important ST segment 
elevation >1 mm in DII, DIII, aVF, with ST depression in 
aVL, flat T waves in V5, and negative T waves in V6 (Figure 
1B). All this confirmed the diagnosis of the ST-segment 
elevation myocardial infarction (STEMI). Therapy with 
low-molecular-weight heparin (enoxaparin), antiplatelets 
(aspirin, clopidogrel), and a statin was initiated immediately, 
while antidote therapy continued. The patient was 
transferred to the Cardiology Department, where ECG 
showed an inferior STEMI and supraventricular tachycardia 
(Figure 1C). LVEF was at 46 %, one third of the basal 
inferolateral and inferior walls were hypokinetic, one third 
of the basal anterior interventricular septum dyskinetic, and 
the aortic valve was calcified. Emergency coronarography 
showed normal epicardial coronary arteries with no obvious 
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Figure 1A Electrocardiogram monitoring showing acute STEMI in inferior territory. ECG upon ED admission shows sinus rhythm, 
ST segment depression in V3-V4, and flat T waves in D1, aVL, V5-V6
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stenotic artery or thrombosis (but a confirmation test of 
coronary vasospasm was not performed). All this confirmed 
the diagnosis of type 2 acute inferior STEMI with normal 
epicardial coronary arteries.
Therapy continued in the Coronary Critical Care Unit 
(CCU) with triple antithrombotic therapy, diltiazem, statin, 
and continued antidote administration and supportive care. 
After development of MI, atropine was administered 
cautiously for the next 2 days, when myosis and signs of 
exocrine gland hypersecretion appeared. 48 hours after 
coronary angiography, the patient developed acute renal 
failure [creatinine 2.15 mg/dL, blood urea nitrogen (BUN) 
87 mg/dL], possibly after contrast substance administration, 
which was successfully addressed in the Cardiology 
Department. She was transferred back to our department to 
complete the medical treatment of MI, OP poisoning, and 
its complications. For three days she was receiving two 
uni ts  of  human plasma a  day for  exogenous 
pseudocholinesterase supply, because her level of 
cholinesterase remained low (1568 U/L) despite obidoxime 
administration for 72 hours since poisoning. Systolic blood 
pressure remained below 110 mmHg, allowing only a low 
dose of ramipril as part of the medical treatment of MI. 
Also, a short episode of nonsustained ventricular 
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Figure 1B Electrocardiogram monitoring showing acute STEMI in inferior territory. ECG 26 hours after admission showed important 
ST segment elevation in leads DII, DIII, aVF, with S-T segment depression in aVL, flat T waves in DI, and V6, and sinus tachycardia
Figure 1C Electrocardiogram monitoring showing acute STEMI in inferior territory. ECG at the Cardiology Department revealed 
acute ST-elevation in inferior territory and sinus tachycardia
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tachycardia occurred during CCU stay, which was resolved 
with lidocaine bolus followed by a 24-hour infusion.
During hospitalisation, the patient developed left 
inferior lobe pneumonia due to infection with Klebsiella 
pneumoniae, which was treated with ciprofloxacin, 
mucolytics, and expectorants. Renal function returned to 
normal, and metabolic and electrolyte derangements were 
all corrected. The level of HbA1c and fasting glucose were 
also normal, which ruled out diabetes as a cardiovascular 
risk factor. The patient was discharged in good condition 
after 11 days, with ECG showing persistent ischaemic 
changes in the inferolateral territory (Figure 1D) Cardiac 
enzymes, liver and renal function, and plasma cholinesterase 
(5463 U/L) were normal.
DISCUSSION
Type 2 MI is a heterogeneous syndrome, which can be 
primary or secondary illness and is caused by either acute 
non atherothrombotic coronary artery disease or other acute 
noncoronary trigger/illness (9). However, the European or 
American STEMI guidelines (10, 11) make no mention of 
acute poisoning (e.g., carbon monoxide, OP, or cyanide 
poisoning) as possible cause. OP poisoning can be followed 
by cardiovascular complications (4) within the first few 
hours. By inhibiting acetylcholinesterase irreversibly, OPs 
can cause acetylcholine to accumulate and overstimulate 
cholinergic synapses in the central nervous system. They 
can also cause heart dysrhythmia, hypertension, or 
hypotension (5, 6). The distinct features of OP poisoning 
include prolonged PQ and QT intervals (responsible for 
ventricular arrhythmia and ventricular fibrillation), ST-T 
changes, AV block, and bradycardia (12, 13). Cardiac 
toxicity starts with a brief period of increased sympathetic 
tone followed by prolonged parasympathetic hyperactivity, 
hypoxemia, acidosis, electrolyte derangements, and a direct 
toxic effect on the myocardium (12, 14). In addition, QT 
prolongation may be followed by torsade de pointes 
ventricular tachycardia and ventricular fibrillation (12). 
Parasympathetic hyperactivity plays a major role in the 
coronary artery spasm, which is an important factor in the 
pathogenesis of type 2 MI (1, 13).
Our patient developed acute type 2 STEMI approximately 
six hours after accidental ingestion of an unknown quantity 
of unknown OP solution. Unknown, as we could not get 
hold of the bottle she later claimed to have mistaken for a 
drink. She confirmed her chronic occupational OP exposure 
in a statement about her work conditions and the use of 
pesticides in her household. Unfortunately, our laboratory 
was not equipped to assess pesticide blood level or its 
metabolites in urine as markers of chronic OP exposure. 
However, we did confirm it by establishing low serum 
butyrylcholinesterase (BChE) activity in a routine screening 
test (15). This and the history of exposure, pesticide breath 
odour, and clinical signs and symptoms including high 
blood pressure and tachycardia on ED admission pointed 
to nicotinic symptoms of OP poisoning. We were also aware 
that tachycardia could have been caused by ethanol 
intoxication, confirmed by the level of blood alcohol, but 
later developments proved our OP poisoning diagnosis 
right.
Pesticides can increase the amount of catecholamines 
and other vasoactive amines, which can cause coronary 
thrombosis or spasm and eventually lead to myocardial 
infarction (16). Ischaemic ECG changes that followed (new 
ST-segment elevation by ≥1 mm and T wave inversion), a 
rise in cTnI, regional wall motion abnormality, and normal 
epicardial coronary arteries on angiography reinforced our 
Figure 1D Electrocardiogram monitoring showing acute STEMI in inferior territory. ECG before discharge showing persistence of 
ischaemic changes in the inferolateral territory
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initial diagnosis of a type 2 MI. We did not have the criteria 
to diagnose myocardial infarction with non-obstructive 
coronary arteries (MINOCA), because the Cardiology 
Department did not test the patient for coronary spasm, and 
coronary angiography did not reveal microvascular 
dysfunction, thrombosis, embolism, plaque disruption, or 
spontaneous coronary artery dissection. Further testing (17, 
18) excluded inherited or acquired hypercoagulable state.
The therapy the patient received needs a separate 
discussion, since there are no specific recommendations in 
the STEMI guidelines (10, 11) for this aetiology of type 2 
MI. Given that we blamed coronary vasospasm for the 
infarction, we chose diltiazem over a beta-blocker for the 
treatment.
Close monitoring of ECG changes in the ED and later 
is very important and can inform further treatment, 
including antidote administration and supportive care (19).
Consistent with acute illness, we interpreted high 
glucose in our patient as stress-induced hyperglycaemia.
When our patient developed nonsustained ventricular 
tachycardia five days since OP exposure, her cholinesterase 
and potassium level were normal. This is why we associated 
it with STEMI and electric instability and not as direct toxic 
damage or hypokalaemia. As the changes in serum 
cholinesterase activities have been implicated in MI, 
acetylcholinesterase and butyrylcholinesterase can serve as 
diagnostic markers for the parasympathetic/sympathetic 
balance and can predict cardiovascular adverse events.
According to Waiskopf et al. (20), about one third of 
severely poisoned patients have elevated troponin I levels, 
indicative of MI, and ST depression and/or elevation are 
more common in patients with elevated TnI. These findings 
are consistent with our case.
Our search of articles published over the last 15 years 
and indexed in PubMed, Oxford Journals, Scopus, Google 
Academic, Science Direct, Springerlink, and Web of 
Science resulted in only 11 case reports of MI following 
OP poisoning (see Table 1), which confirms that this is a 
rare occurrence. MI can occur within hours (4, 19, 20) or 
days after acute OP exposure (16, 23, 24). Two articles (6, 
25) report type 1 MI early after OP exposure. One report 
(23) refers to a patient poisoned with OP who presented 
with out-of-hospital cardiac arrest. This patient was 
successfully resuscitated, the initial ECG showed 
inferolateral ST segment elevation (possible after 
defibrillation), although no coronary artery lesions were 
documented and no troponin elevation recorded. This 
patient does not meet the criteria for diagnosing MI (1). 
Another paper (3) refers to MI occurring seven days after 
parathion ingestion (based on the echocardiography and 
troponin and CKMB levels), but coronary angiography 
revealed a 20 % stenosis of the left anterior descending 
coronary artery consistent with patient’s known history of 
diabetes, and there is no mention of ECG. Because of such 
a delay between OP poisoning and MI, we think that the 
two acute events are associated rather than causally related 
(27). Finally, one paper (28) reported STEMI shortly after 
OP exposure in a young patient, with patent coronary 
arteries on angiography, which might suggest type 2 MI, 
but it does not mention occupational exposure to OP.
Our case is particular inasmuch as our patient had no 
cardiovascular risk factors, had been occupationally 
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Table 1 Case reports of myocardial infarction following organophosphate poisoning
Author Onset after OP exposure
Type of 
poisoning
Type of myocardial 
infarction Coronary angiogram Outcome
Tkaczyk Jędrzej et 
al. (25)
In the same day, 




al. (6) After 1–2 h Accidental Type 1
90 % stenosis of the 
right coronary artery Recovered
Ayyadurai et al. (28) Upon admission Voluntary Type 2 Patent coronaries Recovered
Kidiyoor et al. (3) After 7 days Voluntary Type 2
Left anterior 
descending coronary 
artery 20 % 
obstruction (autopsy)
Dead
Kuo et al. (26) Second night after admission
Not 
specified Inferolateral STEMI
No stenotic artery or 
thrombosis Dead
Pankaj and Krishna (24) After 5 days Not specified STEMI Postponed Recovered
Joshi et al. (23) After 2 days Voluntary STEMI Not performed Recovered
Aydın and Küçüktepe 
(22) At admission Accidental STEMI Not specified Recovered
Kumar et al. (16) After 3 days Voluntary Inferolateral STEMI Not performed Not specified
Mdaghri et al. (21) After 20 hours Not specified
Endocardial 
ischaemia Not specified Dead
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exposed to pesticides for 10 years, and developed type 2 
STEMI within six hours of accidental ingestion. To the best 
of our knowledge, this is the first case of an acute type 2 
MI following accidental poisoning with OP in a patient with 
chronic occupational exposure to OP pesticides. When there 
is a short interval (hours) after an acute exposure to OP, it 
is more likely the relationship between the two situations 
is causal, and the arguments are clearly demonstrated in 
literature (29, 30). A study which analysed pesticide use 
and MI incidence among farm women (31) revealed an 
increased risk of MI associated with low-level pesticide 
exposure in women. This might explain the occurrence of 
type 2 MI in our patient within six hours of accidental 
ingestion of an OP pesticide solution.
In most reports reviewed by DeFilippis et al. (32), 
patients classified as having a type 2 MI were older, more 
often female, with more comorbidities, and a lower peak 
in cTnI. This was the case with our patient too.
Patients with type 2 MI have higher short- and long-term 
mortality than those with type 1 MI (20), and in-hospital 
mortality rates are 2–3 times higher than those reported for 
type 1 MI because of non-cardiovascular events (33). A 
recent study (34) which tested a hypotheses that rise in 
cardiac troponin T (cTnT) and CK-MB follows a different 
pattern between type 1 and type 2 MI and that the ratio of 
cTnT to CK-MB is disproportionately higher in type 2 than 
type 1 MI. It concluded that patients with marked elevations 
in these biomarkers may be more likely to have type 1 MI, 
whereas those with mildly elevated CK-MB and moderately 
elevated cTnI may be more likely to have type 2 MI, which 
was also the case with our patient.
Finally, even though lactic acidosis is associated with 
a higher risk of early death and in-hospital complications 
(35, 36), our patient responded well to the treatment and 
recovered.
CONCLUSION
Even though we had no guidelines to fall back on, we 
successfully treated the patient with low-molecular-weight 
heparin, antiplatelets, statin, diltiazem, low-dose ramipril, 
antidote therapy, and supportive care. We hope that the 
existing STEMI guidelines should include evidence-based 
specific treatment for this toxicological emergency. Type 2 
MI following OP poisoning is a rarely reported complication 
and emergency physicians should be aware of this early 
complication to assess all cardiac biomarkers as soon as a 
patient is admitted to emergency. This might improve the 
outcome and prevent fatalities.
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Neobična etiologija infarkta miokarda tipa 2: pregled temeljen na prikazu slučaja
Otrovanje organofosfatnim pesticidima prilično je često i može dovesti do komplikacija sa srcem i krvožiljem, a ponekad 
i izravno oštetiti srčani mišić. Do sada, međutim, nije zabilježen slučaj infarkta miokarda tipa 2. U ovom je radu prikazan 
slučaj otrovanja 61-godišnjakinje koja je primljena u odjel hitne pomoći jedan sat nakon slučajnoga gutanja nepoznate 
količine otopine koju je upotrebljavala za suzbijanje biljnih uši. Bolesnica je primljena sa znakovima i simptomima 
ošamućenosti, mioze, prekomjernoga znojenja, hipersalivacije, urinarne inkontinencije, mišićne fascikulacije, drhtavice 
u udovima, bljedilom te dahom koji je mirisao na alkohol i pesticide. Premda nije bilo smjernica za liječenje u takvom 
slučaju, primjena heparina niske molekulske mase, antitrombotika, statina, diltiazema, antidota i potpornoga liječenja 
dovela je do povoljnog ishoda. Svrha je ovoga prikaza ukazati liječnicima da otrovanje organofosfatima može uzrokovati 
infarkt miokarda tipa 2, koji se javlja kao komplikacija unutar nekoliko sati od otrovanja, tako da obrada u odjelu hitne 
pomoći svakako treba obuhvatiti i strogi nadzor srčane funkcije.
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